- Home
- Publications
- Publication Search
- Publication Details
Title
Extranodal natural killer/T-cell lymphoma
Authors
Keywords
-
Journal
CURRENT OPINION IN ONCOLOGY
Volume 23, Issue 5, Pages 429-435
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2011-07-09
DOI
10.1097/cco.0b013e328349aba6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Diagnostic and Prognostic Value of Circulating miR-221 for Extranodal Natural Killer/T-Cell Lymphoma
- (2013) Hong-Qiang Guo et al. DISEASE MARKERS
- A promising new regimen for the treatment of advanced extranodal NK/T cell lymphoma
- (2011) Mohamad Farid et al. ACTA ONCOLOGICA
- Guidelines for the management of mature T-cell and NK-cell neoplasms (excluding cutaneous T-cell lymphoma)
- (2011) Claire E. Dearden et al. BRITISH JOURNAL OF HAEMATOLOGY
- Absolute lymphocyte count is a novel prognostic indicator in extranodal natural killer/T-cell lymphoma, nasal type
- (2010) J. J. Huang et al. ANNALS OF ONCOLOGY
- Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study
- (2010) A. Jaccard et al. BLOOD
- Metabolic Activity Measured by F-18 FDG PET in Natural Killer-Cell Lymphoma Compared to Aggressive B- and T-Cell Lymphomas
- (2010) Winnie K. S. Chan et al. CLINICAL NUCLEAR MEDICINE
- Activated oncogenic pathways and therapeutic targets in extranodal nasal-type NK/T cell lymphoma revealed by gene expression profiling
- (2010) Siok-Bian Ng et al. JOURNAL OF PATHOLOGY
- Allogeneic hematopoietic stem cell transplant following chemotherapy containingl-asparaginase as a promising treatment for patients with relapsed or refractory extranodal natural killer/T cell lymphoma, nasal type
- (2010) Hisayuki Yokoyama et al. LEUKEMIA & LYMPHOMA
- Prognostic factors for mature natural killer (NK) cell neoplasms: aggressive NK cell leukemia and extranodal NK cell lymphoma, nasal type
- (2009) R. Suzuki et al. ANNALS OF ONCOLOGY
- Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type
- (2009) Y. Huang et al. BLOOD
- Primary radiotherapy showed favorable outcome in treating extranodal nasal-type NK/T-cell lymphoma in children and adolescents
- (2009) Z.-Y. Wang et al. BLOOD
- Advances in the management and monitoring of extranodal NK/T-cell lymphoma, nasal type
- (2009) Raymond Liang BRITISH JOURNAL OF HAEMATOLOGY
- Phase I/II Study of Concurrent Chemoradiotherapy for Localized Nasal Natural Killer/T-Cell Lymphoma: Japan Clinical Oncology Group Study JCOG0211
- (2009) Motoko Yamaguchi et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial of Concurrent Radiation and Weekly Cisplatin Followed by VIPD Chemotherapy in Newly Diagnosed, Stage IE to IIE, Nasal, Extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma Study
- (2009) Seok Jin Kim et al. JOURNAL OF CLINICAL ONCOLOGY
- Management of T-cell and natural-killer-cell neoplasms in Asia: consensus statement from the Asian Oncology Summit 2009
- (2009) Yok-Lam Kwong et al. LANCET ONCOLOGY
- STAT3 transcription factor is constitutively activated and is oncogenic in nasal-type NK/T-cell lymphoma
- (2009) P Coppo et al. LEUKEMIA
- L-Asparaginase in the treatment of refractory and relapsed extranodal NK/T-cell lymphoma, nasal type
- (2008) Weiben Yong et al. ANNALS OF HEMATOLOGY
- Effective second-line chemotherapy for extranodal NK/T-cell lymphoma consisting of etoposide, ifosfamide, methotrexate, and prednisolone
- (2008) B.-S. Kim et al. ANNALS OF ONCOLOGY
- L-Asparaginase-based treatment of 15 western patients with extranodal NK/T-cell lymphoma and leukemia and a review of the literature
- (2008) A. Jaccard et al. ANNALS OF ONCOLOGY
- Autologous Hematopoietic Stem Cell Transplantation in Extranodal Natural Killer/T Cell Lymphoma: A Multinational, Multicenter, Matched Controlled Study
- (2008) Jeeyun Lee et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project
- (2008) W.-y. Au et al. BLOOD
- Phase I study of dexamethasone, methotrexate, ifosfamide, l-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemia
- (2008) Motoko Yamaguchi et al. CANCER SCIENCE
- International Peripheral T-Cell and Natural Killer/T-Cell Lymphoma Study: Pathology Findings and Clinical Outcomes
- (2008) JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Value of Tumor 18F-FDG Uptake in Patients with Untreated Extranodal Natural Killer/T-Cell Lymphomas of the Head and Neck
- (2008) C. Suh et al. JOURNAL OF NUCLEAR MEDICINE
- Cell death by bortezomib-induced mitotic catastrophe in natural killer lymphoma cells
- (2008) L. Shen et al. MOLECULAR CANCER THERAPEUTICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now